Trials / Completed
CompletedNCT00275210
MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer
Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,246 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the FOLFOX regimen versus LV5FU2 in the adjuvant treatment of stage II and III colon cancer. Primary objective: Disease Free Survival (DFS) Secondary objective: Overall Survival (OS), safety (including long term toxicity)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin (SR96669) |
Timeline
- Start date
- 1998-10-01
- Primary completion
- 2003-04-01
- Completion
- 2003-04-01
- First posted
- 2006-01-11
- Last updated
- 2009-04-20
Locations
19 sites across 19 countries: Australia, Austria, Belgium, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00275210. Inclusion in this directory is not an endorsement.